1-5 of 5
Morgan Anderson-Crannage
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Morgan Anderson-Crannage, Yiouli Panayiota Ktena, Jessica Hochberg, Temima Kanarfogel, John Herrick, Emily Thatcher, Qiuhu Shi, Bruno Hochberg, Yaya Chu, Sankaran Krishnan, Erin Morris, Sandra Fabricatore, John DuFresne, Kenneth R. Cooke, Mitchell S. Cairo
Journal: Blood
Blood (2024) 144 (Supplement 1): 2515.
https://doi.org/10.1182/blood-2024-205971
Published: 2024
Journal Articles

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide and Changes in Plasma Biomarkers in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Morgan Anderson-Crannage, Jessica Hochberg, Temima Kanarfogel, Yiouli Panayiota Ktena, John Herrick, Emily Thatcher, Qiuhu Shi, Bruno Hochberg, Yaya Chu, Sankaran Krishnan, Erin Morris, Sandra Fabricatore, John DuFresne, Kenneth R. Cooke, Mitchell S. Cairo
Journal: Blood
Blood (2023) 142 (Supplement 1): 2520.
https://doi.org/10.1182/blood-2023-180804
Published: 2023
Journal Articles

Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model

Edo Schaefer, Yanling Liao, Morgan Anderson-Crannage, Bruno Hochberg, Hanif Mouehla, Jian Pan, Bernadette Fallon, Janet Ayello, Mitchell S. Cairo
Journal: Blood
Blood (2022) 140 (Supplement 1): 8641–8642.
https://doi.org/10.1182/blood-2022-162820
Published: 2022
Journal Articles

IFN-γ Inhibitors and Ruxolitinib Therapy for Acquired Severe Aplastic Anemia in an Ex-Vivo Model

Edo Schaefer, Yanling Liao, Bernadette Fallon, Janet Ayello, Melanie Peters, Jian Pan, Morgan Anderson-Crannage, Mitchell S Cairo
Journal: Blood
Blood (2021) 138 (Supplement 1): 1123.
https://doi.org/10.1182/blood-2021-147079
Published: 2021
Journal Articles

High Expression of FGF2/SDC1 Signaling Contributes to Poor Clinical Outcome in Hodgkin Lymphoma Patients and SDC1 siRNA Suppresses Proliferation, Migration, and Invasion in Hodgkin Lymphoma Cells

Poonam Nagpal, PhD, Andre Goy, MD, Anju Gangadharan, PhD, Mohamed R. Akl, PhD, Ivan Voznenko, BA, Mihir Soni, BS, Betty Tai, BA, Tasheka Cousins, BA, Tatyana A Feldman, MD, Sathyen A. Prabhu, MS, Amanda Ally, BS, Morgan Anderson-Crannage, BS, Lori A. Leslie, MD, Lady K., MD, Fareeha Kanwal, MS, Tatsunari Tomiyama, BS, Aliya Khurram, MD, Catherine M. Capac, MS, Matthew Gliksman, BS, Despina Helios, Dante B. Descalzi-Montoya, PhD, Andrew L. Pecora, MD, K. Stephen Suh, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1483.
https://doi.org/10.1182/blood.V130.Suppl_1.1483.1483
Published: 2017